a large number of compounds to study the biological mechanisms sufficient for killing or arresting the growth Cambridge, Massachusetts 02142 of a human cancer cell line derived from a clinical specimen. The National Cancer Institute has assembled a large Summary collection of compounds with either potential or demonstrated activity in cancer and viral-related assays. Our We present a method for testing many biological approach is distinct from the NCI's approach in that we mechanisms in cellular assays using an annotated liobtained and tested compounds with a more diverse brary of 2036 small organic molecules. This annotated range of biological activities, including neurologically compound library represents a large-scale collection active compounds, antidiabetic compounds, controlled of compounds with diverse, experimentally confirmed substances, and compounds with many other activities biological mechanisms and effects. We found that this unrelated to cancer and infectious diseases. Our hychemical library is (1) more structurally diverse than pothesis was that an annotated compound library covconventional, commercially available libraries, (2) enering such a wide range of activities would be useful riched in active compounds in a tumor cell viability in many different cell-based assays. This collection is assay, and (3) capable of generating hypotheses recomplementary to the NCI collection, and we have regarding biological mechanisms underlying cellular cently begun to compile a composite set comprising processes. We elucidated biological mechanisms relboth our collection and the NCI diversity set of 1990 evant to the antiproliferative activity of 85 compounds compounds (vide infra). from this library that were selected using a highMany previous studies [8-14] have identified specific throughput cell viability screen. We developed a novel compounds that prevent the growth of tumor cells, a automated scoring system for identifying statistically number of which have been developed into clinically enriched mechanisms among such a subset of comeffective anticancer drugs. In such cases, much effort pounds. This scoring system can identify both prewas required to identify the specific proteins targeted viously known and potentially novel antiproliferative by each of these antitumor agents. We hypothesized mechanisms.
, the middle 80% of descriptor ure 1) despite the fact that a major criterion in the design of the latter two libraries was structural diversity [18, values for the ACL has a wider range than either the Chembridge or Comgenex libraries for most descriptors 20]. The ACL was designed to have broad functional diversity, and it incorporates compounds affecting a (average ratio of ranges, ACL/Chembridge ϭ 1.8), whereas the Chembridge and Comgenex libraries have wide range of biological mechanisms. The observation that the ACL is structurally as well as functionally diverse similar ranges for most descriptors (average ratio of ranges, Comgenex/Chembridge ϭ 1.1). The middle 98% is intriguing but implies no causal relationship between structural and functional diversity. However, these results of ACL descriptor values exhibits an even greater spread relative to the corresponding range for the Chembridge do demonstrate that some commercial libraries fail to test large biologically relevant descriptor ranges, and, and Comgenex libraries ( Figure 1B) . We used a selforganizing map (SOM) [19] to cluster compounds from while there is no evidence that structural diversity per se will yield a higher hit rate, a more structurally diverse the three libraries based on their descriptor values and to illustrate that the ACL spans a different region of library can yield a more structurally diverse set of active compounds. descriptor space and is more diverse than either commercial library (see Supplemental Figure S1 at http:// We anticipated that compounds with previously described biological activity would have a greater probawww.chembiol.com/cgi/content/full/10/9/881/DC1). Table S1 Among the novel antiproliferative mechanisms generily used as antiinfective agents; none of these compounds are described in the literature as having strong ated by this screen, the biological mechanism term "ionophores" was determined to be enriched among the antiproliferative activity in human tumor cells. To quantify this point directly, we determined the number of the hit compounds. The hit compounds narasin, nonactin, thiomuscimol, and valinomycin (Figures 2B and 2C) ap-85 active compounds that were found in at least one Medline record with tumor or cell death-related biologipeared in four Medline records along with the term "ionophores" [35] [36] [37] [38] . In contrast, when 85 randomly secal terms (tumor, tumors, carcinoma, sarcoma, adenocarcinoma, squamous cell carcinoma, small cell carcilected compounds from the ACL were similarly analyzed in 1000 repeated trials, the term ionophore was rarely noma, cell division, antineoplastic agents, cultured tumor cells, phytogenic antineoplastic agents, apoptoassociated (i.e., the term is not promiscuous). This sug- 85 active compounds that decreased viability of A549 lung carcinoma cells were compared to all 2036 compounds in the ACL using a procedure we termed Global Mechanism Extraction. Biological mechanism terms with statistical enrichment among these 85 compounds (score Ͻ.0004, p Ͻ 0.02) are listed. For each biological mechanism term, the table lists the "score," which is the product of (1) the percentile score for the number of Medline records reporting that biological mechanism in this group of 85 hit compounds relative to the distribution obtained for that mechanism when 85 randomly selected compounds are subjected to the same algorithm, and ( The ACL can accelerate the process of identifying these hypotheses can be validated directly. After identifying the 85 compounds that inhibit prolifpromising candidate mechanisms underlying a biological process, but subsequent experimental confirmation eration of A549 cells, we sought to determine whether any of these compounds were A549 selective rather of these proposed mechanisms remains a potentially difficult and ad hoc procedure. The ACL has revealed than being generally cytotoxic toward many cell types. annotated compounds that define, with increasing precision, the biological molecular mechanisms that are We recognized that valinomycin's selectivity for A549 cells relative to MRC9 cells (Table 4 ) could either be due involved in regulating cellular processes. to the reported ionophore activity of valinomycin or due to a novel mechanism. To distinguish between these Significance alternatives, we identified and tested five additional ionophores (narasin, nigericin, salinomycin, enniatin, and Annotated compound libraries are capable of generating hypotheses regarding underlying biological mechammonium ionophore) for their activity in both A549 and MRC9 cells (see Supplemental Figure S2 at Chemistry & anisms, in contrast to traditional compound libraries. Just as in DNA microarray-based transcription profilBiology's website). We tested each compound in six replicates in a dilution series in both cell lines using the ing experiments and proteomic experiments, these hypotheses must ultimately be tested and validated calcein AM viability assay, and determined that these five ionophores displayed A549-selective lethality with using conventional biological methods. It is, however, possible to group compounds from a primary screen no detectable activity in MRC9 cells, although the maximum level of activity and the potency in A549 cells varied on the basis of their mechanistic similarity to guide and prioritize validation studies. We demonstrate a among the compounds. Since we observed that identification of such A549-selective activity is uncommon (Tastrategy for screening an annotated compound library in cellular assays and then generating mechanistic ble 4), our finding that five additional ionophores display A549 selectivity implies that valinomycin's selectivity is hypotheses; this strategy can likely be extended to other cellular phenotypes. For example, we are using due to its ionophore activity.
In summary, we have created a method for evaluating this strategy to identify biological mechanisms underlying Huntington's disease and spinal muscular atronumerous biological mechanisms that may underlie a of the CB library, and the tails of the distribution are symmetrical phy using cell-based models. We propose that such about the CB median for this particular descriptor. by the same mechanism were tested (see Table 4 single score was generated for each mechanism term that ranked our confidence that the mechanism term was associated with the hit brary were retained in this procedure. Using MOE, we calculated 138 molecular descriptors for each compound, including both 1D compounds in the context of the assay. Each score was computed independently across all mechanism terms that co-occurred with (atom counts) and 2D (bond connectivity) descriptors. For each library, the following percentiles were computed for each descriptor any hit compound name. In computing this score, we were interested in answering two questions. First, how many of the hit compounds value distribution: 1, 5, 10, 50, 90, 95, and 99. Different descriptors have vastly disparate ranges; to facilitate comparisons over all the were associated with a given mechanism term in the literature, and second, how many Medline records had both the mechanism term descriptors, each descriptor was normalized to its range in one of the libraries (CB) and also scaled to the CB median. This was and one of our hit compound names? Having many compounds associated with a given mechanism term adds confidence that the accomplished as follows: the unit for descriptor normalization was the 80% range of the CB library (CB_range80), i.e., CB 90th percenmechanism is actually relevant in the context of the assay. Similarly, having many records in Medline containing our hit compounds and tile (CB90) minus CB 10th percentile (CB10). Percentile values for each library were normalized and scaled for each descriptor i as in a particular mechanism term increases our confidence that this biological mechanism is justifiably associated with the hit comthe following example: ACL90 i (normalized) ϭ ACL90Ј i ϭ (ACL90 i Ϫ CB median i ) / CB_range80 i (see Figure 1) 
